Granisetron is a selective serotonin 5-HT3 receptor antagonist commonly utilized as an antiemetic to prevent and manage nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. This… Read more
![Chemical structure of (1R,3r,5S)-9-Azabicyclo[3.3.1]nonan-3-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R3r5S-9-Azabicyclo3.3.1nonan-3-amine.png&w=3840&q=75)
![Chemical structure of (1R,3s,5S)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F76272-41-8-1R3s5S-9-Methyl-9-azabicyclo3.3.1nonan-3-amine.png&w=3840&q=75)
![Chemical structure of (1R,3s,5S)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine Dihydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2118954-10-0-1R3s5S-9-Methyl-9-azabicyclo3.3.1nonan-3-amine-Dihydrochloride.png&w=3840&q=75)
![Chemical structure of (1R,5S,E)-9-Methyl-9-azabicyclo[3.3.1]nonan-3-one oxime](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1R5SE-9-Methyl-9-azabicyclo3.3.1nonan-3-one-oxime.png&w=3840&q=75)




























Granisetron is a selective serotonin 5-HT3 receptor antagonist commonly utilized as an antiemetic to prevent and manage nausea and vomiting associated with chemotherapy, radiotherapy, and surgery. This category offers a comprehensive range of reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope labelled compounds necessary for rigorous pharmaceutical analysis. Laboratories rely on these materials for detailed impurity profiling, method validation, and routine quality control, ensuring strict compliance with international pharmacopeial specifications. Analytical scientists utilize these standards—ranging from oxidative degradation products to specific related compounds—to accurately identify and quantify potential impurities formed during synthesis or storage. By facilitating precise quantitative analysis, these high-quality materials support robust stability studies and method development protocols in accordance with established regulatory standards throughout the drug development and manufacturing lifecycle.